221 related articles for article (PubMed ID: 33282290)
1. BDCA1
Sosa Cuevas E; Ouaguia L; Mouret S; Charles J; De Fraipont F; Manches O; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
Clin Transl Immunology; 2020; 9(11):e1190. PubMed ID: 33282290
[TBL] [Abstract][Full Text] [Related]
2. Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.
Sosa Cuevas E; Valladeau-Guilemond J; Mouret S; Roubinet B; de Fraipont F; Landemarre L; Charles J; Bendriss-Vermare N; Chaperot L; Aspord C
Front Immunol; 2022; 13():1040600. PubMed ID: 36353633
[TBL] [Abstract][Full Text] [Related]
3. Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.
Ouaguia L; Leroy V; Dufeu-Duchesne T; Durantel D; Decaens T; Hubert M; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
Front Immunol; 2019; 10():112. PubMed ID: 30778353
[No Abstract] [Full Text] [Related]
4. Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs.
Ouaguia L; Dufeu-Duchesne T; Leroy V; Decaens T; Reiser JB; Sosa Cuevas E; Durantel D; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
Clin Transl Immunology; 2020; 9(12):e1208. PubMed ID: 33312564
[TBL] [Abstract][Full Text] [Related]
5. Melanoma tumour-derived glycans hijack dendritic cell subsets through C-type lectin receptor binding.
Niveau C; Sosa Cuevas E; Roubinet B; Pezet M; Thépaut M; Mouret S; Charles J; Fieschi F; Landemarre L; Chaperot L; Saas P; Aspord C
Immunology; 2024 Feb; 171(2):286-311. PubMed ID: 37991344
[TBL] [Abstract][Full Text] [Related]
6. Diversification of circulating and tumor-infiltrating plasmacytoid DCs towards the P3 (CD80
Sosa Cuevas E; Bendriss-Vermare N; Mouret S; De Fraipont F; Charles J; Valladeau-Guilemond J; Chaperot L; Aspord C
Clin Transl Immunology; 2022; 11(5):e1382. PubMed ID: 35517992
[TBL] [Abstract][Full Text] [Related]
7. The melanoma tumor glyco-code impacts human dendritic cells' functionality and dictates clinical outcomes.
Sosa Cuevas E; Roubinet B; Mouret S; Thépaut M; de Fraipont F; Charles J; Fieschi F; Landemarre L; Chaperot L; Aspord C
Front Immunol; 2023; 14():1120434. PubMed ID: 36891308
[TBL] [Abstract][Full Text] [Related]
8. Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes.
Girard P; Sosa Cuevas E; Ponsard B; Mouret S; Gil H; Col E; De Fraipont F; Sturm N; Charles J; Manches O; Chaperot L; Aspord C
Clin Transl Immunology; 2021; 10(11):e1329. PubMed ID: 34786191
[TBL] [Abstract][Full Text] [Related]
9. Fully closed and automated enrichment of primary blood dendritic cells for cancer immunotherapy.
Schreibelt G; Duiveman-de Boer T; Pots JM; van Oorschot TGM; de Boer AJ; Scharenborg NM; van de Rakt MWMM; Bos K; de Goede AL; Petry K; Brüning M; Angerer C; Schöggl C; Dzionek A; de Vries IJM
Methods Cell Biol; 2024; 183():33-50. PubMed ID: 38548417
[TBL] [Abstract][Full Text] [Related]
10. Clonal lineage tracing reveals shared origin of conventional and plasmacytoid dendritic cells.
Feng J; Pucella JN; Jang G; Alcántara-Hernández M; Upadhaya S; Adams NM; Khodadadi-Jamayran A; Lau CM; Stoeckius M; Hao S; Smibert P; Tsirigos A; Idoyaga J; Reizis B
Immunity; 2022 Mar; 55(3):405-422.e11. PubMed ID: 35180378
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor Zeb2 regulates development of conventional and plasmacytoid DCs by repressing Id2.
Scott CL; Soen B; Martens L; Skrypek N; Saelens W; Taminau J; Blancke G; Van Isterdael G; Huylebroeck D; Haigh J; Saeys Y; Guilliams M; Lambrecht BN; Berx G
J Exp Med; 2016 May; 213(6):897-911. PubMed ID: 27185854
[TBL] [Abstract][Full Text] [Related]
12. Clinically applicable CD34
van Eck van der Sluijs J; van Ens D; Thordardottir S; Vodegel D; Hermens I; van der Waart AB; Falkenburg JHF; Kester MGD; de Rink I; Heemskerk MHM; Borst J; Schaap NPM; Jansen JH; Xiao Y; Dolstra H; Hobo W
Cancer Immunol Immunother; 2021 Nov; 70(11):3167-3181. PubMed ID: 33796917
[TBL] [Abstract][Full Text] [Related]
13. Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.
Fu C; Peng P; Loschko J; Feng L; Pham P; Cui W; Lee KP; Krug AB; Jiang A
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23730-23741. PubMed ID: 32879009
[TBL] [Abstract][Full Text] [Related]
14. Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxygenase 1 with functional effects on T cell priming.
Sittig SP; van Beek JJP; Flórez-Grau G; Weiden J; Buschow SI; van der Net MC; van Slooten R; Verbeek MM; Geurtz PBH; Textor J; Figdor CG; de Vries IJM; Schreibelt G
Eur J Immunol; 2021 Jun; 51(6):1494-1504. PubMed ID: 33675038
[TBL] [Abstract][Full Text] [Related]
15. Detection of dendritic cell subsets in the tumor microenvironment by multiplex immunohistochemistry.
van der Hoorn IAE; Martynova E; Subtil B; Meek J; Verrijp K; Textor J; Flórez-Grau G; Piet B; van den Heuvel MM; de Vries IJM; Gorris MAJ
Eur J Immunol; 2024 Jan; 54(1):e2350616. PubMed ID: 37840200
[TBL] [Abstract][Full Text] [Related]
16. DC-Based Vaccines for Cancer Immunotherapy.
Fu C; Zhou L; Mi QS; Jiang A
Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33255895
[TBL] [Abstract][Full Text] [Related]
17. Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation.
Sosa Cuevas E; Saas P; Aspord C
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190135
[TBL] [Abstract][Full Text] [Related]
18. Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination.
van Beek JJP; Flórez-Grau G; Gorris MAJ; Mathan TSM; Schreibelt G; Bol KF; Textor J; de Vries IJM
Cell Rep; 2020 Jan; 30(4):1027-1038.e4. PubMed ID: 31995747
[TBL] [Abstract][Full Text] [Related]
19. Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer.
Mastelic-Gavillet B; Sarivalasis A; Lozano LE; Wyss T; Inoges S; de Vries IJM; Dartiguenave F; Jichlinski P; Derrè L; Coukos G; Melero I; Harari A; Romero P; Viganó S; Kandalaft LE
Eur J Cancer; 2020 Aug; 135():173-182. PubMed ID: 32590296
[TBL] [Abstract][Full Text] [Related]
20. Human Blood CD1c+ Dendritic Cells Encompass CD5high and CD5low Subsets That Differ Significantly in Phenotype, Gene Expression, and Functions.
Yin X; Yu H; Jin X; Li J; Guo H; Shi Q; Yin Z; Xu Y; Wang X; Liu R; Wang S; Zhang L
J Immunol; 2017 Feb; 198(4):1553-1564. PubMed ID: 28087664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]